Join us at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Thursday 10th July for an expert-led discussion exploring the latest trends, challenges, and strategic considerations shaping global pricing and market access (GPMA).
At Petauri Evidence, our Global Pricing and Market Access Team are growing to meet the increasing complexity of global launch and access, bringing together fresh perspectives and decades of real-world experience. In this webinar, our experts, Clare Foy and Adam Brown, are joined by two new additions to the team, Catherine Beecher and Sam Davies, who bring extensive expertise from both consultancy and industry.
Ben Spurr (Head of Partnerships, Petauri Evidence) will host the live panel discussion with Clare, Adam, Catherine, and Sam as they explore the key issues facing Pharmaceutical and Medtech companies as they prepare for global launch, navigate payer expectations, and develop value-driven pricing strategies.
This is your chance to put your questions directly to our GPMA Directors and gain insights from their real-world experience supporting global market access strategies.
Together, they will discuss:
Register now to join us live at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Thursday 10th July or to access the recording later.
Please do register, even if you can’t attend on the day, as all registrants will receive the recording after the event.
Who should attend?
This webinar is ideal for professionals working in:
Whether you’re preparing for a global launch, refining your pricing strategy, or navigating complex payer environments, this webinar will offer practical insights and expert perspectives to support your success.
The webinar is free and open to all market access, pricing, evidence strategy, HEOR, and value communication teams in Pharmaceutical, Medical Device, Diagnostic, and Health tech companies. Some colleagues from other organisations may attend at the discretion of Petauri Evidence.